Skip to content
  • Tuesday, 27 October 2026
  • 8:05 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Telomir Pharmaceuticals Submits Investigational New Drug Application for Telomir-1 to FDA for Advanced Triple-Negative Breast Cancer
Pharmaceutical R&D

Telomir Pharmaceuticals Submits Investigational New Drug Application for Telomir-1 to FDA for Advanced Triple-Negative Breast Cancer

Teuku Ryan Apr 2, 2026 0

Telomir Pharmaceuticals has taken a significant stride in its mission to combat advanced and metastatic triple-negative breast cancer (TNBC) by…

Read More
Stem Cell & Regenerative Medicine

Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels

Dwi Wanna Mar 23, 2026 0

The phenomenon of cancer recurrence remains one of the most significant challenges in modern oncology, particularly in the context of…

Read More
Pharmaceutical R&D

Novartis Acquires Promising Breast Cancer Drug SNV4818 from Synnovation Therapeutics for Up to $3 Billion

Teuku Ryan Mar 20, 2026 0

Novartis has announced a significant strategic move to bolster its oncology pipeline with the acquisition of SNV4818, an investigational oral…

Read More

Posts pagination

1 2 3
Unprecedented Cellular Atlas Reveals Shared Aging Pathways Across Mammalian Tissues, Offering New Avenues for InterventionBiotech Sector Thrives on Collaboration and Innovation, Charting Course for Future Discoveries at Major 2026 Scientific GatheringsNigerian Research Highlights Water-in-Diesel Emulsion as a Critical Breakthrough for Global Emission Reduction and Engine EfficiencyThe Rise of AI Software Clones: Why REA and ArtCraft Are Going Viral
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Sci-Fi Becomes Reality: North Carolina State University Researchers Successfully Demonstrate a Working Plasma Lightsaber AntennaParadigm-Shifting Discovery Reveals Immune Cells as the Primary Driver of Alzheimer’s-Related Sleep DisruptionGroundbreaking Genetic Study Reveals Explosive Growth Rates of Chronic Myeloid Leukemia Years Before DiagnosisThe Roadmap to Becoming a Computer Vision Engineer in 2026: Mastering Spatial Computing, Foundation Models, and Edge Deployment
YOU MAY HAVE MISSED
Advanced Materials Science
Sci-Fi Becomes Reality: North Carolina State University Researchers Successfully Demonstrate a Working Plasma Lightsaber Antenna
Nila Kartika Wati Oct 27, 2026
Neuroscience & Brain Research
Paradigm-Shifting Discovery Reveals Immune Cells as the Primary Driver of Alzheimer’s-Related Sleep Disruption
Rifan Muazin Oct 27, 2026
Stem Cell & Regenerative Medicine
Groundbreaking Genetic Study Reveals Explosive Growth Rates of Chronic Myeloid Leukemia Years Before Diagnosis
Dwi Wanna Oct 27, 2026
Data Science & Bioinformatics
The Roadmap to Becoming a Computer Vision Engineer in 2026: Mastering Spatial Computing, Foundation Models, and Edge Deployment
Evan Lee Salim Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ